B · Normal
On September 3, due to the failure of late-stage trials of the drug, ULTRAGENYX’s stock price plummeted 47% before the market opened.
Related telegraphs
[Goldman Sachs: Hedge funds are reducing their holdings of technology stocks at
10-20 01:42
[Apple announces that it will hold a press conference on October 28 to launch th
10-20 00:35
On October 20th, Cognizant and Google Cloud expanded their cooperation alliance
10-20 00:02
[The Nasdaq 100 Index's increase expanded to 2%, SK Hynix, Intel, etc. rose more
10-19 23:30
October 19th: Dan Lin, head of Netflix’s film division, was fired this weekend.
10-19 23:22
On October 19th, the Nasdaq index expanded to 1.5%.
10-19 23:06
Comments